Zdrowie i gospodarka · 01/04/2021

FDA Corrects Inaccurate Cross-References in Drug Establishment Registration and Listing Regulations

The FDA has corrected inaccurate cross-references in its drug establishment registration and listing regulations, which were published on August 31, 2016. The corrections aim to improve clarity and accuracy in the regulations governing human and animal drugs.